Yapay Zeka Hızlı Bakış & Çıkarımlar
AI InsightThere is an ongoing need for studies on effect, adverse effects, and efficacy of the Inactive Sars-Cov-2 vaccine as Phase III results have not been published yet.
📌 3 Maddede Bu Makale
Abstract
Covid-19 is a contagious viral infection with serious complications. Since a proven treatment for such a disease with high mortality has not yet been found, vaccination studies are important for preventative measures and rapid herd immunity. In a period when the whole world urgently needs vaccines, objective scientific data on about the safety of the vaccine are necessary. After the Sars-Cov-2 vaccine (CoronaVac) first and second dose was administered to the employees of Ufuk University Faculty of Medicine, the adverse effects they encountered in the early period were requested. 173 participants completed the survey. When systemic and local adverse effects seen in the first week after vaccination are reported, most of the adverse effects observed were mild adverse effects. Anaphylaxis with dyspnea and syncope developed on only one participant after vaccination. No serious adverse effects of the Sars-Cov-2 vaccine, whose Phase I / II studies have been published, have been reported. In our study where we evaluated early adverse effects with a limited number of participants, we did not find any serious adverse effects in healthcare workers. Anaphylaxis with dyspnea and syncope was observed in one participant that recovered. There is an ongoing need for studies on effect, adverse effects, and efficacy of the Inactive Sars-Cov-2 vaccine as Phase III results have not been published yet.